SPRB
Income statement / Annual
Last year (2023), Spruce Biosciences, Inc.'s total revenue was $10.09 M,
and the percentage change from the previous year is not available.
In 2023, Spruce Biosciences, Inc.'s net income was -$47.92 M.
See Spruce Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$10.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$49.43 M |
$429,000.00 |
$381,000.00 |
$102,000.00 |
$12,000.00 |
$1,000.00 |
| Gross Profit |
-$39.34 M |
-$429,000.00 |
-$381,000.00 |
-$102,000.00 |
-$12,000.00 |
-$1,000.00 |
| Gross Profit Ratio |
-3.9 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$49.43 M
|
$35.20 M
|
$30.70 M
|
$23.85 M
|
$10.82 M
|
$8.40 M
|
| General & Administrative
Expenses |
$12.65 M
|
$12.09 M
|
$11.37 M
|
$5.56 M
|
$2.29 M
|
$1.57 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$12.65 M
|
$12.09 M
|
$11.37 M
|
$5.56 M
|
$2.29 M
|
$1.57 M
|
| Other Expenses |
$0.00 |
$0.00 |
$119,000.00 |
$200,000.00 |
$84,000.00 |
$114,000.00 |
| Operating Expenses |
$62.08 M |
$47.28 M |
$42.07 M |
$29.42 M |
$13.11 M |
$9.97 M |
| Cost And Expenses |
$62.08 M |
$47.28 M |
$42.07 M |
$29.42 M |
$13.11 M |
$9.97 M |
| Interest Income |
$4.56 M |
$1.52 M |
$119,000.00 |
$123,000.00 |
$19,000.00 |
$0.00 |
| Interest Expense |
$483,000.00 |
$420,000.00 |
$345,000.00 |
$323,000.00 |
$65,000.00 |
$0.00 |
| Depreciation &
Amortization |
$70,000.00
|
$429,000.00
|
$381,000.00
|
$102,000.00
|
$12,000.00
|
$1,000.00
|
| EBITDA |
-$47.37 M
|
-$45.33 M
|
-$41.57 M
|
-$29.11 M
|
-$13.10 M
|
-$9.97 M
|
| EBITDA Ratio |
-4.69 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-5.15
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$4.07 M
|
$1.10 M
|
-$226,000.00
|
-$123,000.00
|
$19,000.00
|
$114,000.00
|
| Income Before Tax |
-$47.92 M |
-$46.18 M |
-$42.29 M |
-$29.54 M |
-$13.09 M |
-$9.86 M |
| Income Before Tax Ratio
|
-4.75
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$1.10 M |
$396,000.00 |
$487,000.00 |
$149,000.00 |
$114,000.00 |
| Net Income |
-$47.92 M |
-$45.08 M |
-$42.69 M |
-$30.03 M |
-$13.24 M |
-$9.86 M |
| Net Income Ratio |
-4.75 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.24 |
-1.92 |
-1.83 |
-1.29 |
-0.59 |
-2.01 |
| EPS Diluted |
-1.24 |
-1.92 |
-1.83 |
-1.29 |
-0.59 |
-2.01 |
| Weighted Average Shares
Out |
$38.51 M
|
$23.53 M
|
$23.36 M
|
$23.26 M
|
$22.26 M
|
$4.89 M
|
| Weighted Average Shares
Out Diluted |
$38.51 M
|
$23.53 M
|
$23.36 M
|
$23.26 M
|
$22.26 M
|
$4.89 M
|
| Link |
|
|
|
|
|
|
